D-serine Adjuvant Treatment for Parkinson's Disease

NCT00215904 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: D-serine (~2g/day)

Sponsor

Herzog Hospital